ArticleNeuroImage2025
Neurochemical changes in GABA+, Glx, and the excitatory/inhibitory ratio in the calcarine cortex with healthy aging.
Article in NeuroImage, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Elevated neurotransmitter levels in people with HIV are associated with attention function.Neurobiology of disease · 2026Article
- Relationship between brain metabolites and chronic pain mechanisms in knee osteoarthritis pre- and post-total knee replacement.Neurobiology of pain (Cambridge, Mass.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Aging has been associated with widespread alterations in neural structure and function, but the underlying biochemical changes remain less understood despite recent neurophysiological work suggesting age-related alterations in the excitatory/inhibitory (E/I) balance. In the current study, we used ¹H-MRS to quantify levels of excitatory (Glx: glutamate + glutamine) and inhibitory (GABA+: GABA + macromolecules) neurotransmitters in the calcarine cortex in 187 healthy adults (19-79 years-old). These neurotransmitter estimates were used to compute the E/I ratio, and all three parameters were examined for aging effects. Given our large sample, we also conducted supplementary analyses to estimate the concentration of secondary metabolites commonly implicated in aging, including total creatine (tCr), total N-acetyl aspartate (tNAA), total choline (tCho), and myo-inositol (mI). Following best practices, metabolite concentrations were estimated relative to the unsuppressed water signal and corrected for voxel tissue composition (i.e., gray matter, white matter, CSF). Our results indicated significant age-related declines in both GABA+ and Glx, along with a reduction in the E/I ratio, suggesting diminished inhibitory and excitatory tone with advancing age. We also found a decline in tNAA and an increase in tCr with increasing age. In summary, we provide compelling evidence through one of the largest studies of its kind for age-related shifts in excitatory and inhibitory neurotransmitter levels in the visual cortex. These changes may be critical to well-known, age-related physiological changes, including reduced neural selectivity and processing efficiency. These findings provide novel evidence that neurochemical alterations may contribute to the functional declines in cortical processing seen in healthy aging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.